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INTRODUCTION:  Congenital  factor  VII  deﬁciency  is a rare bleeding  disorder  with  high  phenotypic  vari-
ability.  It  is critical  that  children  with  congenital  Factor  VII  deﬁciency  be  identiﬁed  early  when  high-risk
surgery  is planned.  Cranial  vault  surgery  is common  for children  with  craniosynostosis,  and  these  surg-
eries  are  associated  with  signiﬁcant  morbidity  mostly  secondary  to the  risk  of massive  blood  loss.
PRESENTATION  OF  CASE:  A  two-month  old  infant  who  presented  for elective  craniosynostosis  repair  was
noted  to have  an  elevated  prothrombin  time  (PT)  with  a normal  activated  partial  thromboplastin  time
(aPTT)  on  preoperative  labs.  The  infant  had  no  clinical  history  or reported  family  history  of  bleeding
disorders,  therefore  a multidisciplinary  decision  was  made  to repeat  the  labs  under general  anesthesia
and  await  the  results  prior  to incision.  The  results  conﬁrmed  the  abnormal  PT  and the  case  was can-
celed.  Hematologic  workup  during  admission  revealed  factor  VII  deﬁciency.  The  patient  underwent  an
uneventful  endoscopic  strip  craniectomy  with  perioperative  administration  of  recombinant  Factor  VIIa.
DISCUSSION:  Important  considerations  for perioperative  laboratory  evaluation  and  management  in chil-
dren with factor  VII  deﬁciency  are  discussed.  Anesthetic  and  surgical  management  of  the  child  with
factor  VII  deﬁciency  necessitates  meticulous  planning  to prevent  life  threatening  bleeding  during  the
perioperative  period.
CONCLUSION:  A thorough  history  and  physical  examination  with  a high  clinical  suspicion  are vital  in pre-
venting  hemorrhage  during  surgeries  in  children  with  coagulopathies.  Abnormal  preoperative  lab  values
should always  be  conﬁrmed  and addressed  before  proceeding  with  high-risk  surgery.  A multidisciplinary
optim
 Publi
he  CCdiscussion  is essential  to  
© 2016  The  Authors.
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. Introduction
Factor VII deﬁciency is a rare autosomal recessive disorder,
ith an incidence of 1:500,000 [1]. Most severe cases of factor
II deﬁciency are diagnosed during childhood, often during the
rst 6 months of life. In infants, the most common bleeds occur
n the gastrointestinal tract or central nervous system [1]. Post-
perative bleeding has been reported in association with 30% of
actor VII deﬁcient patients undergoing surgical procedures, even
Abbreviations: PT, prothrombin time; PTT, partial thromboplastin time;
NR, international normalized ratio; CBC, complete blood count; CMP, complete
etabolic panel.
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210-2612/© 2016 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing G
reativecommons.org/licenses/by-nc-nd/4.0/).ize  the  risk-beneﬁt  ratio  during  the  perioperative  period.
shed  by  Elsevier  Ltd  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
 BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
when replacement therapy was prophylactically administered [2].
Anesthetic and surgical management of the child with factor
VII deﬁciency necessitates meticulous planning to prevent life-
threatening bleeding during the perioperative period. We  present
the case of a child with an undiagnosed factor VII deﬁciency
revealed by preoperative laboratory studies collected in prepara-
tion for craniosynostosis repair.
2. Presentation of case
An otherwise healthy 2 month old female presented to
same-day care for elective sagittal craniosynostosis repair. Her
preoperative labs from three days prior included a prolonged
prothrombin time (PT) of 27 s with a normal activated partial
thromboplastin time (aPTT), hemoglobin, and platelet count. A type
and cross for blood was also sent. There was no history of bleed-
ing in the infant and no family history of bleeding disorders. After
discussions with neurosurgery, the team decided to repeat the labs
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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nder general anesthesia given the reassuring history and await
he results prior to incision.
An inhalation induction and endotracheal intubation was per-
ormed uneventfully. A peripheral intravenous catheter was placed
nd a “superstat” comprehensive metabolic panel (CMP), complete
lood count (CBC), PT, aPTT and ﬁbrinogen were sent. The CMP
howed no signs of liver dysfunction and the CBC was  unchanged
rom prior results. The repeat value for the PT was  29 s, with an
NR of 2.9. aPTT and ﬁbrinogen were normal. The surgery was can-
eled and the infant was extubated without complications. She was
dmitted to the pediatric hematology service for further workup
nd found to have factor VII deﬁciency, with a factor VII level of
0% (reference range 39–191%).
The infant was rescheduled for endoscopic strip craniectomy
uring the same admission and recombinant Factor VIIa was
dministered throughout the case. The surgery was uneventful and
he was discharged home four days post-operatively with pediatric
ematology follow-up. She had no bleeding complications in the
welve months post-surgery.
. Discussion
Congenital factor VII deﬁciencies have a high genotypic and phe-
otypic variation, and there is no consistent correlation between
leeding symptoms and factor VII levels [3]. Often the patients
ay  be asymptomatic or are diagnosed after surgery related bleed-
ng. Craniosynostosis is the result of premature fusion of one or
ore cranial sutures and can be classiﬁed as non-syndromic or
yndromic with an underlying genetic alteration found in some
ases. Our patient had sagittal craniosynostosis, or scaphocephaly,
he most common form of non-syndromic craniosynostosis. The
ncidence of craniosynostosis is approximately 1 in 2100 children.
nrepaired craniosynostosis can lead to impaired brain growth,
ncreased intracranial pressure, and severe craniofacial deformi-
ies. In order to achieve optimal surgical results, craniosynostosis
epairs are performed in the ﬁrst year of life. Because of the nature
f the repair, the patient’s young age, and new diagnosis of factor
II deﬁciency, this surgery would be associated with an increased
isk of morbidity and mortality secondary to intraoperative blood
oss [4,5].
Craniofacial syndromes are typically associated with craniosyn-
stosis and include Apert’s and Crouzon’s syndrome which are
ssociated with cognitive dysfunction, musculoskeletal deformi-
ies, airway abnormalities, and cardiac defects. There has been no
eport of coagulopathies associated with these syndromes. Another
orm of craniosynostosis is termed “secondary craniosynostosis”
hich includes metabolic disorders (ie hypothyroidism), fetal ter-
togen exposure, and mucopolysaccharidosis all of which are not
ound to be associated with bleeding disorders (Kohl et al. [4]).
n the literature to date, there are several syndromes and genetic
utations associated with craniosynostosis but none with an asso-
iation with Factor VII deﬁciency or other coagulation disorders. In
009, a case report by Maquoi and colleagues described the diag-
osis of Von Willebrand’s disease as an incidental ﬁnding in a child
ndergoing craniosynostosis repair during the preoperative visit
ue to a positive family history—no direct association has been
eported [6].
Preoperative laboratory evaluation should at minimum include
 type and cross to ascertain availability of crossmatched blood
rior to incision. Other recommended laboratory evaluation
ncludes a hematocrit, platelet count, and coagulation studies as
hey can be helpful in establishing a baseline prior to surgery.
owever, these studies are normal in the vast majority of non-
yndromic children [5]. There are no pediatric-speciﬁc guidelines
or preoperative coagulation testing. Often, testing is performed
olely based on clinician-speciﬁc practice. A review of the litera-PEN  ACCESS
rgery Case Reports 24 (2016) 77–79
ture demonstrates that routine preoperative coagulation screening
may  serve as a useful complement to a positive personal or family
bleeding history; but may  otherwise be futile in identifying occult
bleeding disorders in children [4]. However, this child had no clini-
cal bleeding history, therefore a decision not to obtain labs based on
a negative history may  have contributed to harm in this case. Nev-
ertheless, if preoperative testing is performed, it is imperative that
the anesthesiology and surgery teams review this data and proceed
systematically to address abnormal values rather than assume they
are spurious. Although no bleeding history may  seem reassuring,
the patient may  not be old enough to have a bleeding history [7]. In
this patient, the elevated PT and INR warranted further evaluation,
and a repeat sample was obtained after the child was anesthetized
but before incision given the child’s negative bleeding history and
to ensure that an adequate and high-quality sample was obtained,
minimizing the chance of a false positive result.
Formulation of the differential diagnosis of elevated PT requires
a thorough understanding of the extrinsic pathway of the coag-
ulation cascade. Abnormalities in the tissue factor, or extrinsic
pathway, affect the PT, whereas the contact activation, or intrin-
sic pathway, affects the aPTT. Any abnormalities in the common
pathway will affect both the aPTT and PT. The differential diag-
nosis of elevated PT with a normal aPTT includes: tissue factor
(extrinsic) deﬁciency, warfarin or rodenticide ingestion, liver dys-
function, or vitamin K deﬁciency [4]. Warfarin or rodenticide
ingestion was unlikely. The normal comprehensive metabolic panel
ruled out liver dysfunction. Although infants are at risk for vita-
min  K deﬁciency due to a lack of gut ﬂora resulting in intestinal
malabsorption, this infant was born in a hospital and received
routine vitamin K prophylaxis at birth. Also, vitamin K deﬁciency
would result in deﬁciency in the other vitamin K dependent fac-
tors, namely factors II, IX, and X. Thus, the patient has an extrinsic
deﬁciency.
Treatment of acute hemorrhage and surgical prophylaxis in
patients with factor VII deﬁciency consists of factor VII replacement
therapy. Pediatric hematology should be immediately consulted
and dependent on the severity of deﬁciency, recombinant Factor
VIIa (rFVIIa) should be administered at the time of induction and at
least 15 min prior to incision. The ﬁrst dose is 15–30 mcg/kg. Due to
its short half-life, it must be re-dosed every 6 h for 24–48 h there-
after at the same dose. Factor VIIa replacement therapy with rFVIIa
may  also be delivered safely as continuous infusion and this mode
of administration is highly cost-effective [8,9] rFVIIa increases the
risk of thrombosis and development of new inhibitors, although
the incidence of these risks is low in the literature [10].
4. Conclusion
In summary, congenital factor VII deﬁciency may present with-
out signs of bleeding and pose both diagnostic and management
challenges for both the anesthesia and surgical teams. A thorough
history and physical examination together with a high clinical
suspicion are vital in preventing catastrophic hemorrhage dur-
ing surgeries in children with coagulopathies. In the setting of
abnormal pre-operative coagulation values, a multidisciplinary dis-
cussion is essential to optimize the risk-beneﬁt ratio when planning
how to move forward.
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